(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 51.48% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.01%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.06%.
Invivyd's revenue in 2026 is $60,685,000.On average, 5 Wall Street analysts forecast IVVD's revenue for 2026 to be $18,112,790,382, with the lowest IVVD revenue forecast at $16,600,927,583, and the highest IVVD revenue forecast at $20,238,976,784. On average, 5 Wall Street analysts forecast IVVD's revenue for 2027 to be $26,224,345,232, with the lowest IVVD revenue forecast at $20,830,832,342, and the highest IVVD revenue forecast at $31,351,789,189.
In 2028, IVVD is forecast to generate $69,370,083,294 in revenue, with the lowest revenue forecast at $51,280,352,219 and the highest revenue forecast at $87,879,612,017.